Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : HEPA    save search

Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial
Published: 2024-04-19 (Crawled : 20:00) - globenewswire.com
HEPA | $1.39 -6.71% -7.19% 37K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

pharmaceuticals trial
Hepion Pharmaceuticals Strengthens Board of Directors with Appointment of Michael Purcell
Published: 2024-03-06 (Crawled : 13:30) - globenewswire.com
EXPR | $0.83 -9.64% 440K twitter stocktwits trandingview |
Retail Trade
| | O: 4.04% H: 2.59% C: -1.29%
IMXI | $22.17 1.28% 1.26% 200K twitter stocktwits trandingview |
Finance
| | O: 2.51% H: 2.35% C: 0.83%
HEPA | $1.39 -6.71% -7.19% 37K twitter stocktwits trandingview |
Health Technology
| | O: -1.15% H: 4.28% C: -10.89%

pharmaceuticals
Hepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross Proceeds
Published: 2024-02-16 (Crawled : 13:00) - globenewswire.com
HEPA | $1.39 -6.71% -7.19% 37K twitter stocktwits trandingview |
Health Technology
| | O: -15.19% H: 52.4% C: 11.79%

million pharmaceuticals
Non-Alcoholic Fatty Liver Disease Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies - MediciNova, Eli Lilly and Company, AstraZeneca, Madrigal Pharmaceuticals, BioMarin Pharmaceutical, GlaxoSmithKline, Pfizer
Published: 2024-01-22 (Crawled : 22:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.51% H: 0.37% C: 0.32%
MDGL | $204.51 -6.35% -6.78% 580K twitter stocktwits trandingview |
Health Technology
| | O: 1.29% H: 0.35% C: -3.04%
HEPA | $1.39 -6.71% -7.19% 37K twitter stocktwits trandingview |
Health Technology
| | O: -0.48% H: 7.69% C: 1.44%
ALT | $7.095 -6.28% -6.69% 2.2M twitter stocktwits trandingview |
Commercial Services
| | O: -0.8% H: 6.02% C: 0.6%
ALNY | $143.8 -1.55% -1.58% 390K twitter stocktwits trandingview |
Health Technology
| | O: 0.46% H: 3.04% C: 2.67%
ETNB | $8.59 -3.7% -3.84% 870K twitter stocktwits trandingview |
Health Technology
| | O: 1.19% H: 0.63% C: -0.72%

liver disease companies key growth market
Hepion Pharmaceuticals to Present at NASH-TAG 2024
Published: 2024-01-03 (Crawled : 22:00) - globenewswire.com
HEPA | $1.39 -6.71% -7.19% 37K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 1.29% C: -4.67%

pharmaceuticals
Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes
Published: 2023-12-07 (Crawled : 13:00) - globenewswire.com
HEPA | $1.39 -6.71% -7.19% 37K twitter stocktwits trandingview |
Health Technology
| | O: -1.85% H: 3.46% C: -3.77%

management pharmaceuticals
Hepion Pharmaceuticals to Present at the 7th Obesity & NASH Drug Development Summit
Published: 2023-11-28 (Crawled : 21:00) - globenewswire.com
HEPA | $1.39 -6.71% -7.19% 37K twitter stocktwits trandingview |
Health Technology
| | O: 0.33% H: 2.25% C: -1.77%

obesity drug pharmaceuticals nash
Hepion Pharmaceuticals Announces Major Reductions in Liver Stiffness with Rencofilstat Treatment in 17-week Phase 2 Study of Advanced (F3) MASH Liver Disease
Published: 2023-11-13 (Crawled : 21:00) - globenewswire.com
HEPA | $1.39 -6.71% -7.19% 37K twitter stocktwits trandingview |
Health Technology
| | O: -17.36% H: 16.86% C: 2.46%

liver disease treatment pharmaceuticals study
Hepion Pharmaceuticals Schedules Conference Call to Review Additional Efficacy Data from Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial of Rencofilstat
Published: 2023-11-10 (Crawled : 14:00) - globenewswire.com
HEPA | $1.39 -6.71% -7.19% 37K twitter stocktwits trandingview |
Health Technology
| | O: 2.05% H: 29.77% C: 1.34%

liver conference review pharmaceuticals trial phase 2
Here's how much WeWork co-founder Adam Neumann made before the company's bankruptcy – NBC Southern California
Published: 2023-11-07 (Crawled : 04:00) - spacfeed.com
HEPA | $1.39 -6.71% -7.19% 37K twitter stocktwits trandingview |
Health Technology
| | O: -0.52% H: 2.86% C: -6.25%

california
Stock futures slip after Nasdaq registers 7-day win streak: Live updates – CNBC
Published: 2023-11-07 (Crawled : 04:00) - spacfeed.com
HEPA | $1.39 -6.71% -7.19% 37K twitter stocktwits trandingview |
Health Technology
| | O: -0.52% H: 2.86% C: -6.25%

nasdaq
Milk Makeup Owner Waldencast at Risk of Nasdaq Delisting – Yahoo Movies UK
Published: 2023-11-06 (Crawled : 03:00) - spacfeed.com
HEPA | $1.39 -6.71% -7.19% 37K twitter stocktwits trandingview |
Health Technology
| | O: -0.52% H: 2.86% C: -6.25%

nasdaq risk
‘Natural Killer’ Cell Maker Goes Public – Orange County Business Journal
Published: 2023-11-07 (Crawled : 03:00) - spacfeed.com
HEPA | $1.39 -6.71% -7.19% 37K twitter stocktwits trandingview |
Health Technology
| | O: -0.52% H: 2.86% C: -6.25%

business cell
Here's how much WeWork co-founder Adam Neumann made before the company's bankruptcy – CNBC
Published: 2023-11-07 (Crawled : 03:00) - spacfeed.com
HEPA | $1.39 -6.71% -7.19% 37K twitter stocktwits trandingview |
Health Technology
| | O: -0.52% H: 2.86% C: -6.25%


Aurelia may have golden future: FitzGerald – The Cairns Post
Published: 2023-11-07 (Crawled : 02:00) - spacfeed.com
HEPA | $1.39 -6.71% -7.19% 37K twitter stocktwits trandingview |
Health Technology
| | O: -0.52% H: 2.86% C: -6.25%


Milk Makeup Owner Waldencast at Risk of Nasdaq Delisting – Yahoo Lifestyle UK
Published: 2023-11-06 (Crawled : 01:00) - spacfeed.com
HEPA | $1.39 -6.71% -7.19% 37K twitter stocktwits trandingview |
Health Technology
| | O: -0.52% H: 2.86% C: -6.25%

nasdaq risk
LAZYDAYS ANNOUNCES ACQUISITION OF STORE IN ST … – PR Newswire
Published: 2023-11-06 (Crawled : 01:00) - spacfeed.com
HEPA | $1.39 -6.71% -7.19% 37K twitter stocktwits trandingview |
Health Technology
| | O: -0.52% H: 2.86% C: -6.25%

acquisition store
Comment Open On 20 Proposed WDFW Acquisitions – – Northwest Sportsman Magazine
Published: 2023-11-07 (Crawled : 01:00) - spacfeed.com
HEPA | $1.39 -6.71% -7.19% 37K twitter stocktwits trandingview |
Health Technology
| | O: -0.52% H: 2.86% C: -6.25%

acquisitions
WeWork Stock Trading Halted Amid Bankruptcy Rumors … – Commercial Observer
Published: 2023-11-06 (Crawled : 00:00) - spacfeed.com
HEPA | $1.39 -6.71% -7.19% 37K twitter stocktwits trandingview |
Health Technology
| | O: -0.52% H: 2.86% C: -6.25%

commercial rumors
JELD-WEN Reports Third Quarter 2023 Results and Updates Full … – PR Newswire
Published: 2023-11-06 (Crawled : 23:00) - spacfeed.com
HEPA | $1.39 -6.71% -7.19% 37K twitter stocktwits trandingview |
Health Technology
| | O: -0.52% H: 2.86% C: -6.25%

results
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.